Back
Cardiff Oncology, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
5
CRDF
Cardiff Oncology, Inc.
Last Price:
$1.57
Seasonality Move:
-2.87%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRDF is experiencing slight selling pressure.
Cardiff Oncology, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.58 | Sell |
| 20-day SMA: | 2.08 | Sell |
| 50-day SMA: | 2.41 | Sell |
| 200-day SMA: | 2.65 | Sell |
| 8-day EMA: | 1.49 | Buy |
| 20-day EMA: | 1.07 | Buy |
| 50-day EMA: | 0.57 | Buy |
| 200-day EMA: | 0.17 | Buy |
Cardiff Oncology, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.42 | Buy |
| Relative Strength Index (14 RSI): | 31.81 | Sell |
| Chaikin Money Flow: | -27041 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.6 - 2.9) | Sell |
| Bollinger Bands (100): | (1.89 - 2.71) | Sell |
Cardiff Oncology, Inc. Technical Analysis
| Jan 30 | Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | |||||||||
| 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cardiff Oncology, Inc. Stock
Is Cardiff Oncology, Inc. Stock a Buy?
-
Cardiff Oncology, Inc. share price is 1.58 while CRDF 8-day simple moving average is 1.58, which is a Sell signal.
-
The stock price of CRDF is 1.58 while Cardiff Oncology, Inc. 20-day SMA is 2.08, which makes it a Sell.
-
Cardiff Oncology, Inc. 50-day simple moving average is 2.41 while CRDF share price is 1.58, making it a Sell technically.
-
CRDF stock price is 1.58 and Cardiff Oncology, Inc. 200-day simple moving average is 2.65, creating a Sell signal.
CRDF Technical Analysis vs Fundamental Analysis
Sell
5
Cardiff Oncology, Inc. (CRDF)
is a Sell
Is Cardiff Oncology, Inc. a Buy or a Sell?
-
Cardiff Oncology, Inc. stock is rated a SellThe current Cardiff Oncology, Inc. [CRDF] share price is $1.58. The Score for CRDF is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
Cardiff Oncology, Inc. Stock Info
Market Cap:
106.4M
Price in USD:
1.58
Share Volume:
405.6K
Cardiff Oncology, Inc. 52-Week Range
52-Week High:
4.99
52-Week Low:
1.48
Sell
5
Cardiff Oncology, Inc. (CRDF)
is a Sell
Cardiff Oncology, Inc. Share Price Forecast
-
What is the Cardiff Oncology, Inc. stock price today?The Cardiff Oncology, Inc. stock price is 1.58 USD today.
-
Will CRDF stock go up or go down?Cardiff Oncology, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Cardiff Oncology, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cardiff Oncology, Inc. is overvalued.
Is Cardiff Oncology, Inc. Stock a Buy?
-
Cardiff Oncology, Inc. share price is 1.58 while CRDF 8-day exponential moving average is 1.49, which is a Buy signal.
-
The stock price of CRDF is 1.58 while Cardiff Oncology, Inc. 20-day EMA is 1.07, which makes it a Buy.
-
Cardiff Oncology, Inc. 50-day exponential moving average is 0.57 while CRDF share price is 1.58, making it a Buy technically.
-
CRDF stock price is 1.58 and Cardiff Oncology, Inc. 200-day simple moving average is 0.17, creating a Buy signal.
Fundamental Analysis of Cardiff Oncology, Inc.
Is Cardiff Oncology, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.16 per share.
Technical Analysis of Cardiff Oncology, Inc.
Should I short Cardiff Oncology, Inc. stock?
-
CRDF Moving Average Covergence Divergence (MACD) indicator is 0.42, suggesting Cardiff Oncology, Inc. is a Buy
-
Cardiff Oncology, Inc. Relative Strength Index (RSI) is 31.81, which suggest Cardiff Oncology, Inc. is oversold
-
The Bollinger Bands (25) for Cardiff Oncology, Inc. is (1.6 - 2.9), which suggest Cardiff Oncology, Inc. is a Sell
-
The Bollinger Bands (100) for Cardiff Oncology, Inc. is (1.89 - 2.71), which suggest Cardiff Oncology, Inc. is a Sell
* Cardiff Oncology, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.